Pricing Log in Create free account

Eledon Pharmaceuticals, Inc. (ELDN) vs ProQR Therapeutics N.V. (PRQR)

Eledon Pharmaceuticals, Inc. and ProQR Therapeutics N.V. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. is the larger, with a market value of $211.7M against $190.5M — 1.1× the size. Eledon Pharmaceuticals, Inc. has the higher net margin (0.00% vs −228.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Eledon Pharmaceuticals, Inc. leads on 8 and ProQR Therapeutics N.V. on 5.

Valuation

Metric ELDN PRQR Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6.92 9.40
P/B 8.98 1.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.06 9.02
Earnings yield (34.87%) (34.07%) (32.88%)
Free cash flow yield (24.90%) (38.66%) (23.13%)

Profitability

Metric ELDN PRQR Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (233.33%) 0.00%
Net margin 0.00% (228.71%) 0.00%
Free cash flow margin 0.00% (267.36%) 0.00%
Return on equity (236.51%) (58.29%) (51.96%)
Return on assets (72.74%) (31.53%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELDN PRQR Biotechnology median
Revenue growth (TTM) — 19.72% 6.76%
EPS growth (last fiscal year) 30.67% (28.57%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELDN PRQR Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 7.90 3.49 4.97
Net debt to EBITDA 1.60 2.15 1.01

Dividend

Metric ELDN PRQR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELDN PRQR Biotechnology median
Market cap 211.69m 190.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack